cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Voyager Therapeutics Inc
17 own
24 watching
Current Price
$8.1
$-0.78
(-8.78%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
312.01M
52-Week High
52-Week High
10.815
52-Week Low
52-Week Low
3
Average Volume
Average Volume
0.56M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
7.6651
iconMarket Capitalization312.01M
icon52-Week High10.815
icon52-Week Low3
iconAverage Volume0.56M
iconDividend Yield--
iconP/E Ratio7.6651
What does the Voyager Therapeutics Inc do?
Gene therapy biotech targeting Parkinson's disease and other CNS disorders.
Read More
How much money does Voyager Therapeutics Inc make?
News & Events about Voyager Therapeutics Inc.
Zolmax
9days ago
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Rock Ventures Iii L.P. Third sold 100,000 shares of the stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $9.15, for a total value of $915,000.00. Following the transaction, ...
Ticker Report
9days ago
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Rock Ventures Iii L.P. Third sold 100,000 shares of the stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $9.15, for a total value of $915,000.00. Following the ...
Ticker Report
21days ago
Voyager Therapeutics, Inc. (NASDAQ:VYGR Get Rating) major shareholder Ecor1 Capital, Llc sold 456,000 shares of the companys stock in a transaction on Monday, January 9th. The stock was sold at an average price of $7.67, for a total transaction of $3,497,520.00. Following the ...
Globe Newswire
26days ago
- Voyager to receive up-front consideration of $175 million including a $39 million equity investment, up to $1.5 billion in potential development milestones, additional potential commercial milestones, tiered royalties on net sales, program funding, and an option to elect 50/50 cost- and profit-...
Zolmax
2 months ago
StockNews.com upgraded shares of Voyager Therapeutics (NASDAQ:VYGR Get Rating) from a hold rating to a buy rating in a research report sent to investors on Monday. Voyager Therapeutics Stock Down 5.8 % VYGR stock opened at $5.21 on Monday. The firm has a market cap of $201.14 million, a PE ratio of...
Frequently Asked Questions
Frequently Asked Questions
What is Voyager Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Voyager Therapeutics Inc shares?
plus_minus_icon
How can I buy Voyager Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Voyager Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Voyager Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Voyager Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Voyager Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Voyager Therapeutics Inc?
plus_minus_icon
What percentage is Voyager Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Voyager Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.1
$-0.78
(-8.78%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00